title: Safety and tolerability of combination antiretroviral post-exposure prophylaxis in a population-based setting.
authors: Paula
authors: P
authors: Braitstein
authors: Keith
authors: K
authors: Chan
authors: Ann
authors: A
authors: Beardsell
authors: Alistair
authors: A
authors: McLeod
authors: Julio S G
authors: JS
authors: Montaner
authors: Michael V
authors: MV
authors: O'Shaughnessy
authors: Robert S
authors: RS
authors: Hogg
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018890:Chemoprevention; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D019259:Lamivudine / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D019888:Nelfinavir / Q000009:adverse effects* / Q000627:therapeutic use; D016273:Occupational Exposure; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D018119:Stavudine / Q000009:adverse effects* / Q000627:therapeutic use; D011795:Surveys and Questionnaires
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D018119:Stavudine; D019888:Nelfinavir